The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Eisai
Travel, Accommodations, Expenses - BeiGene
Incidence of osteonecrosis of the jaw (ONJ) in the randomized non-inferiority phase III trial SAKK 96/12 REDUSE comparing denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w).
 
Roger Anton Fredy Von Moos
Honoraria - Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; InnoMedica; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; PharmaMar; Roche; Seagen; Vifor Pharma
Expert Testimony - Seagen
Travel, Accommodations, Expenses - Takeda (Inst)
 
Andreas Mueller
Honoraria - Gilead Sciences; Novartis
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Innomedica; Lilly; Merck Sharp & Dohme; Novartis; Pfizer
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Gilead Sciences; Pfizer; Roche
 
Stefanie Hayoz
No Relationships to Disclose
 
Michael Thomas Mark
Consulting or Advisory Role - AstraZeneca; bms; MSD Oncology; Roche; Takeda
Research Funding - Gilead Sciences (Inst); Swiss Cancer Research Foundation (Inst)
Travel, Accommodations, Expenses - Merck (Inst); Roche (Inst); Takeda (Inst)
 
Stefanie Fischer
Stock and Other Ownership Interests - Amgen (I)
Consulting or Advisory Role - Ipsen (Inst)
Speakers' Bureau - Janssen (Inst)
Travel, Accommodations, Expenses - Bayer (Inst)
 
Razvan A. Popescu
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Kaiku Health (Inst); Lilly (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Kaiku Health (Inst); Lilly (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
 
Mathias Konrad Fehr
Consulting or Advisory Role - AstraZeneca
 
Claudine Egger
No Relationships to Disclose
 
Sandro Anchisi
Consulting or Advisory Role - Gilead Sciences
 
Florian Schmid
No Relationships to Disclose
 
Khalil Zaman
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi (Inst); Gilead Sciences (Inst); Seagen (Inst)
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Pierre Fabre (Inst); Roche
Other Relationship - Daiichi Sankyo Europe GmbH (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
 
Christoph J Ackermann
Consulting or Advisory Role - BMSi (Inst)
Travel, Accommodations, Expenses - BMSi
 
Alexander Schreiber
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck; MSD; Pfizer; Roche; Tesaro; Vifor Pharma
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Ipsen; Lilly; Roche; Vifor Pharma
 
Priska Bützberger
Travel, Accommodations, Expenses - SERVIER (I)
 
Catrina Uhlmann Nussbaum
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Pierre Fabre (Inst)
Travel, Accommodations, Expenses - BeiGene; Pierre Fabre
 
Marc Küng
Consulting or Advisory Role - Amgen; Bayer; Merck; Pfizer
Travel, Accommodations, Expenses - Amgen; Gilead Sciences; Janssen
 
Corinne Schaer
No Relationships to Disclose
 
Silke Gillessen
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); InnoMedica (Inst); Ipsen (Inst); Macrogenics (Inst); MSD Oncology (Inst); Myriad Genetics (Inst); Orion (Inst); PeerVoice (Inst); WebMD/Medscape (Inst)
Speakers' Bureau - AdMeTech Foundation (Inst); ASCO GU (Inst); EPG Health (Inst); ESMO (Inst); German-speaking European School of Oncology (DESO); Intellisphere (Inst); Meister ConCept GmbH (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Group for Clinical Cancer Research (SAKK); Swiss Group for Clinical Cancer Research (SAKK) (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Gilead Sciences; Intellisphere
Other Relationship - Cold Spring Harbor Laboratory (Inst); ProteoMediX
 
Arnoud J. Templeton
Honoraria - Bayer (Inst); Janssen
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb/Pfizer (Inst); Ipsen (Inst); Merck; MSD; MSD (Inst); Pfizer (Inst); Pfizer (Inst); Sandoz (Inst)
Travel, Accommodations, Expenses - Orion Health; Roche